Using AI to improve Digestive Healthcare
Description
In this awesome episode, Nick discusses with Alex Menys, CEO of Motilent, their current growth and more broadly the state of AI in MedTech.
Alex Menys is the CEO of Motilent and his main focus is around measuring treatment response in Crohn's Disease but he is also actively involved in a range of projects around all things gastro including constipation, gastroparesis, IBS and any disease that features some form of GI symptom. Motilent specialises in the assessment of digestive diseases using medical image analysis. Their primary focus areas include Crohn’s Disease, Irritable Bowel Syndrome (IBS) and Gastroparesis although they support a range of projects across Digestive Health.
This is a really intriguing episode because the clinical pathway of Motilent is so complex, and therefore Alex is a huge advocate and very vocal voice for the change needed within the Digestive Health pathway.
United States
